SCOPE-PD: Explainable AI on Subjective and Clinical Objective Measurements of Parkinson's Disease for Precision Decision-Making
Fuente:
arXiv
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Preprint |
| Veröffentlicht: |
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866915944209580032 |
|---|---|
| author | Islam, Md Mezbahul Templeton, John Michael Sobhan, Masrur Poellabauer, Christian Mondal, Ananda Mohan |
| author_facet | Islam, Md Mezbahul Templeton, John Michael Sobhan, Masrur Poellabauer, Christian Mondal, Ananda Mohan |
| contents | Parkinson's disease (PD) is a chronic and complex neurodegenerative disorder influenced by genetic, clinical, and lifestyle factors. Predicting this disease early is challenging because it depends on traditional diagnostic methods that face issues of subjectivity, which commonly delay diagnosis. Several objective analyses are currently in practice to help overcome the challenges of subjectivity; however, a proper explanation of these analyses is still lacking. While machine learning (ML) has demonstrated potential in supporting PD diagnosis, existing approaches often rely on subjective reports only and lack interpretability for individualized risk estimation. This study proposes SCOPE-PD, an explainable AI-based prediction framework, by integrating subjective and objective assessments to provide personalized health decisions. Subjective and objective clinical assessment data are collected from the Parkinson's Progression Markers Initiative (PPMI) study to construct a multimodal prediction framework. Several ML techniques are applied to these data, and the best ML model is selected to interpret the results. Model interpretability is examined using SHAP-based analysis. The Random Forest algorithm achieves the highest accuracy of 98.66 percent using combined features from both subjective and objective test data. Tremor, bradykinesia, and facial expression are identified as the top three contributing features from the MDS-UPDRS test in the prediction of PD. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2601_22516 |
| institution | arXiv |
| publishDate | 2026 |
| record_format | arxiv |
| spellingShingle | SCOPE-PD: Explainable AI on Subjective and Clinical Objective Measurements of Parkinson's Disease for Precision Decision-Making Islam, Md Mezbahul Templeton, John Michael Sobhan, Masrur Poellabauer, Christian Mondal, Ananda Mohan Machine Learning Artificial Intelligence Parkinson's disease (PD) is a chronic and complex neurodegenerative disorder influenced by genetic, clinical, and lifestyle factors. Predicting this disease early is challenging because it depends on traditional diagnostic methods that face issues of subjectivity, which commonly delay diagnosis. Several objective analyses are currently in practice to help overcome the challenges of subjectivity; however, a proper explanation of these analyses is still lacking. While machine learning (ML) has demonstrated potential in supporting PD diagnosis, existing approaches often rely on subjective reports only and lack interpretability for individualized risk estimation. This study proposes SCOPE-PD, an explainable AI-based prediction framework, by integrating subjective and objective assessments to provide personalized health decisions. Subjective and objective clinical assessment data are collected from the Parkinson's Progression Markers Initiative (PPMI) study to construct a multimodal prediction framework. Several ML techniques are applied to these data, and the best ML model is selected to interpret the results. Model interpretability is examined using SHAP-based analysis. The Random Forest algorithm achieves the highest accuracy of 98.66 percent using combined features from both subjective and objective test data. Tremor, bradykinesia, and facial expression are identified as the top three contributing features from the MDS-UPDRS test in the prediction of PD. |
| title | SCOPE-PD: Explainable AI on Subjective and Clinical Objective Measurements of Parkinson's Disease for Precision Decision-Making |
| topic | Machine Learning Artificial Intelligence |
| url | https://arxiv.org/abs/2601.22516 |